Kazia Therapeutics Limited American Depositary Shares (KZIA) Stock Price

KZIAStock

$13.58+75.68%52W

Market Cap$155.18M

P/E—

PEG Ratio1.01

Div yield—

Beta2.26

KZIA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)95.72%

Price vs S&P 500 (4W)7.89%

PEG Ratio1.01

VGM Score48.53

Book Value / Share (Quarterly)$0.01

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)279.24%

Cash Flow / Share (Quarterly)$-0.00

Price vs S&P 500 (YTD)84.28%

Gross Margin (TTM)77.70%

Net Profit Margin (TTM)-9259.16%

EPS (TTM)$-0.01

10-Day Avg Trading Volume0.31M

EPS Excl Extra (TTM)$-0.01

Revenue Growth (5Y)11.58%

EPS (Annual)$-0.03

ROI (Annual)-147.79%

Gross Margin (Annual)77.60%

Net Profit Margin (5Y Avg)-261385.72%

Cash / Share (Quarterly)$0.01

Revenue Growth QoQ (YoY)461.28%

ROA (Last FY)-341.56%

Revenue Growth TTM (YoY)-89.49%

EBITD / Share (TTM)$-0.01

ROE (5Y Avg)-97.91%

Operating Margin (TTM)-10667.11%

Cash Flow / Share (Annual)$-0.01

P/B Ratio4.59x

P/B Ratio (Quarterly)0.33x

EV / Revenue (TTM)642.32x

Net Interest Coverage (TTM)-77.23x

ROA (TTM)-59.09%

EPS Incl Extra (Annual)$-0.03

Current Ratio (Annual)0.35x

Quick Ratio (Quarterly)2.86x

3-Month Avg Trading Volume0.22M

52-Week Price Return75.68%

Tangible BV / Share (Quarterly)$0.01

P/S Ratio (Annual)1871.51x

Asset Turnover (Annual)0.02x

52-Week High$12.46

Operating Margin (5Y Avg)-265734.98%

EPS Excl Extra (Annual)$-0.03

26-Week Price Return107.65%

Quick Ratio (Annual)0.32x

13-Week Price Return7.18%

Total Debt / Equity (Annual)0.15x

Current Ratio (Quarterly)2.87x

Enterprise Value$113.31M

Revenue / Share Growth (5Y)-25.98%

Asset Turnover (TTM)0.01x

Inventory Turnover (Annual)1.54x

Pretax Margin (Annual)-19691.23%

Cash / Share (Annual)$0.00

3-Month Return Std Dev86.00%

Gross Margin (5Y Avg)70.65%

ROE (Last FY)-169.83%

Net Interest Coverage (Annual)-7.40x

EPS Basic Excl Extra (Annual)$-0.03

Receivables Turnover (TTM)34.73x

Total Debt / Equity (Quarterly)0.31x

EPS Incl Extra (TTM)$-0.01

Receivables Turnover (Annual)7606.56x

ROI (TTM)-20.66%

P/S Ratio (TTM)866.40x

Pretax Margin (5Y Avg)-265457.64%

Revenue / Share (Annual)$0.00

Price vs S&P 500 (52W)57.12%

Year-to-Date Return97.10%

5-Day Price Return2.88%

EPS Normalized (Annual)$-0.03

ROA (5Y Avg)-124.54%

Net Profit Margin (Annual)-18159.65%

Month-to-Date Return7.61%

EBITD / Share (Annual)$-0.03

Operating Margin (Annual)-21075.44%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-91.00%

LT Debt / Equity (Quarterly)0.32x

EPS Basic Excl Extra (TTM)$-0.01

P/TBV (Quarterly)0.34x

Inventory Turnover (TTM)1.54x

Pretax Margin (TTM)-9913.15%

Price vs S&P 500 (13W)5.23%

Beta2.26x

P/FCF (Annual)333.36x

Revenue / Share (TTM)$0.00

ROE (TTM)-27.01%

52-Week Low$3.48

vGradeF

gGradeC

mGradeB

vgmGradeC

KZIA Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.11

4.10

4.18

Industry Peers — Pharmaceuticals(570)

Symbol	Value Score	Growth Score	Momentum Score	Price
KZIAKazia Therapeutics Limited American Depositary Shares	F	C	B	$13.58
LLYEli Lilly & Co.	D	B	C	$1174.61
JNJJohnson & Johnson	D	C	B	$268.04
ABBVABBVIE INC.	D	C	B	$255.48
MRKMerck & Co., Inc.	D	C	B	$148.35
NVSNovartis AG	C	C	C	$153.81
AZNAstraZeneca PLC	C	B	C	$162.70
NVONovo-Nordisk A/S	B	C	C	$45.61
ABTAbbott Laboratories	C	C	C	$112.47
PFEPfizer Inc.	C	D	B	$27.96
VRTXVertex Pharmaceuticals Inc	D	C	B	$541.69
BMYBristol-Myers Squibb Co.	B	B	B	$66.58
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$44.82
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$50.82
REGNRegeneron Pharmaceuticals Inc	C	C	B	$794.19
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	$18.03
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$36.44
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	$366.73
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$60.85
ZTSZOETIS INC.	C	C	D	$77.34
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$237.10
INSMInsmed, Inc.	F	A	C	$118.54
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$34.71
UTHRUnited Therapeutics Corp	C	C	B	$515.46
GMABGenmab A/S ADS	C	C	B	$33.23
VTRSViatris Inc. Common Stock	B	C	B	$16.34
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$247.91
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$244.54
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$76.60
BMRNBioMarin Pharmaceuticals Inc	C	C	B	$64.67
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	B	$533.76
CORTCorcept Therapeutics Inc.	F	C	B	$113.88
ELANElanco Animal Health Incorporated Common Stock	C	B	C	$24.11
ARWRArrowhead Research Corporation	D	A	B	$84.91
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.73
AXSMAxsome Therapeutics, Inc	D	B	C	$199.02
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.18
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$61.05
CYTKCytokinetics Inc.	F	D	C	$72.09
ABVXAbivax SA American Depositary Shares	—	—	C	$113.35
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$344.75
PTGXProtagonist Therapeutics, Inc	F	B	B	$144.33
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.84
TGTXTG Therapeutics, Inc.	D	B	B	$53.93
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	$90.36
ALKSAlkermes Inc. plc	D	C	B	$47.41
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$107.17
ERASErasca, Inc. Common Stock	—	—	A	$18.03
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$65.67
BLTEBelite Bio, Inc American Depositary Shares	—	—	C	$151.72

About Kazia Therapeutics Limited American Depositary Shares

Kazia Therapeutics is an oncology-focused biotechnology company developing targeted cancer therapies. Its lead program, Paxalisib, is an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway designed to treat brain cancers. The company maintains operations in Australia and the United States and has a portfolio of additional development candidates across various cancer indications.